Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H V Semlitsch

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Zeitschrift Fur Experimentelle Psychologie : Organ Der Deutschen Gesellschaft Fur Psychologie|November 2, 2001
[Possible confounding variables on the flicker-fusion frequency: temperament, well-being, cognitive information processing speed]M Langecker, L Linzmayer, H V Semlitsch
Electroencephalography and Clinical Neurophysiology|November 1, 1996
Multichannel auditory event-related brain potentials: effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudesP Anderer, H V Semlitsch, B Saletu
European Journal of Clinical Pharmacology|January 1, 1995
Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjectsH V Semlitsch, P Anderer, B Saletu
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementiaH V Semlitsch, P Anderer, B Saletu
Neuropsychobiology|January 1, 1990
Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairmentH V Semlitsch, P Anderer, B Saletu, et al.
Neuropsychobiology|January 1, 1993
Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG resultsP Anderer, M J Barbanoj, B Saletu, et al.
Psychiatry Research|August 1, 1992
Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacologyP Anderer, H V Semlitsch, B Saletu, et al.
Neurobiology of Aging|February 26, 2003
Non-invasive localization of P300 sources in normal aging and age-associated memory impairmentP Anderer, B Saletu, H V Semlitsch, et al.
Methods and Findings in Experimental and Clinical Pharmacology|February 11, 2003
Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugsP Anderer, B Saletu, H V Semlitsch, et al.
Neuropsychobiology|January 1, 1990
EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trialsB Saletu, J Grünberger, L Linzmayer, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Zeitschrift Fur Experimentelle Psychologie : Organ Der Deutschen Gesellschaft Fur Psychologie|November 2, 2001
[Possible confounding variables on the flicker-fusion frequency: temperament, well-being, cognitive information processing speed]M Langecker, L Linzmayer, H V Semlitsch
Electroencephalography and Clinical Neurophysiology|November 1, 1996
Multichannel auditory event-related brain potentials: effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudesP Anderer, H V Semlitsch, B Saletu
European Journal of Clinical Pharmacology|January 1, 1995
Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjectsH V Semlitsch, P Anderer, B Saletu
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementiaH V Semlitsch, P Anderer, B Saletu
Neuropsychobiology|January 1, 1990
Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairmentH V Semlitsch, P Anderer, B Saletu, et al.
Neuropsychobiology|January 1, 1993
Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG resultsP Anderer, M J Barbanoj, B Saletu, et al.
Psychiatry Research|August 1, 1992
Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacologyP Anderer, H V Semlitsch, B Saletu, et al.
Neurobiology of Aging|February 26, 2003
Non-invasive localization of P300 sources in normal aging and age-associated memory impairmentP Anderer, B Saletu, H V Semlitsch, et al.
Methods and Findings in Experimental and Clinical Pharmacology|February 11, 2003
Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugsP Anderer, B Saletu, H V Semlitsch, et al.
Neuropsychobiology|January 1, 1990
EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trialsB Saletu, J Grünberger, L Linzmayer, et al.
Pageof 3